+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free
Published Date: 2017-06-20Number of Pages: 163

Non-opioid Pain Patch Market (Patch Type - Lidocaine Patches, Diclofenac Patches, Methyl Salicylate Patches, Capsaicin Patches, Ketoprofen Patches; Distribution Channel - Hospital Pharmacies, Online Pharmacies, and Independent Pharmacies and Drug Stores) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Global Non-opioid Pain Patch Market: Snapshot

The increasing epidemic of opioid abuse and misuse has necessitated the use of safer, non-addicting analgesics to relive pain. Acute/chronic pain is among the most common complaints that patients seek emergency medical care for. According to the U.S. National Prescription Audit, opioid prescriptions dispended by retail pharmacies increased from 76 million in 1997 to 219 million in 2011.

The reduction in opioid prescriptions is estimated to result in increased usage of non-opioid therapeutics for treating pain thereby driving expansion of the non-opioid pain patch market. Non-opioid pain patch available in various types are effective for certain types of pain. They are safe and well-tolerated and have little risk of systemic side-effects and drug interactions.

The increasing incidence of pain-related disorders and increasing global spending on pain management treatments is anticipated to positively impact the global non-opioid pain patch market.

On the contrary, low adoption rate of non-opioid pain patch is challenging the growth of this market. This is because oral pain relieving drugs act in a short duration of time and act directly on the central nervous system thus preventing the pain sensation. The increasing success of implants for long-term pain relief is also detrimental to the non-opioid pain patch market. These minimally invasive procedures deliver excellent clinical success and have been acting as long-term pain relief solution for patients globally.

The global non-opioid pain patch market stood at US$3,750 mn in 2015 and is expected to reach a valuation of US$4,983.3 mn by 2024 rising at a CAGR of 3.3% between 2016 and 2024.

non opioid pain patch market

 

Methyl Salicylate Patch Type Segment to Display Significant Growth Rate in Future

In terms of patch type, the non-opioid pain patch market is segmented into lidocaine patches, methyl salicylate patches, ketoprofen patches, diclofenac patches, capsaicin patches, and others. Among these, the segment of lidocaine patches led the non-opioid pain patch market in 2015; however, due to patent expiration of lidocaine patch and availability of generic substitutes, this segment is expected to display a declined growth rate. On the other hand, the segment of methyl salicylate is expected to rise at a significant CAGR during the forecast period. The growth of this segment is attributed to faster pain relief, efficient drug delivery for prolonged duration, and increasing number of manufacturers.

On the basis of distribution channel, the global non-opioid pain patch market is segmented into hospital pharmacies, independent pharmacies, online pharmacies, and drug stores.

Asia Pacific to Emerge as Significant Market

In terms of geography, the non-opioid pain patch market is classified into North America, Asia Pacific, Europe, Latin America, and the Middle East and Africa. Among these, North America led the global non-opioid pain patch market in 2015 and is expected to account for a massive 51.5% of the overall market by 2024. According to statistics of the global Burden of Disease, in 2014, back pain was ranked amongst the top ten diseases and injuries that led to death across the world, with the U.S. leading amongst all. Healthcare services in the U.S. spend about US$ 50 bn every year due to back pain related concerns.

Asia Pacific is expected to emerge as a significant market for non-opioid pain patch expanding at a CAGR of 3.5% between 2016 and 2024.

Some of the key companies in the global non-opioid pain patch market are Acorda Therapeutics Inc., ALLERGAN, GlaxoSmithKline plc, IBSA Institut Biochimque SA, Pfizer Inc., Teikoku seiyaku Co. Ltd., Endo International plc, Hisamitsu Pharmaceutical Co. Inc., Mylan N.V., and TEH SENG Pharmaceutical Mfg Co. Ltd among others. 

1. Preface
     1.1. Market Definition and Scope
     1.2. Market Segmentation
     1.3. Key Research Objectives
     1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Non-opioid Pain Patch Market

4. Market Overview
     4.1. Introduction
             4.1.1. Non-opioid Pain Patch Type Definition
             4.1.2. Industry Evolution / Developments
     4.2. Overview
     4.3. Key Market Indicators
     4.4. Market Dynamics
             4.4.1. Drivers
             4.4.2. Restraints
             4.4.3. Opportunity
     4.5. Global Non-opioid Pain Patch Market Analysis and Forecasts, 2014–2024
             4.5.1. Market Revenue Projections (US$ Mn)
     4.6. Porter’s Five Force Analysis
     4.7. Market Outlook
     4.8. WHO Pain Ladder 
     4.9. Low Back Pain Prevalence (By Region & Countries
     4.10. Patch Design Technologies: Snapshot

5. Global Non-opioid Pain Patch Market Analysis and Forecasts, By Non-opioid Pain Patch Type 
     5.1. Introduction & Definition
     5.2. Key Findings / Developments
     5.3. Key Trends
     5.4. Market Value Forecast By Non-opioid Pain Patch Type, 2014–2024
             5.4.1. Lidocaine Patches
             5.4.2. Diclofenac Patches
             5.4.3. Methyl Salicylate Patches
             5.4.4. Capsaicin Patches
             5.4.5. Ketoprofen Patches
             5.4.6. Others
     5.5. Market Attractiveness By Non-opioid Pain Patch Type 

6. Global Non-opioid Pain Patch Market Analysis and Forecasts, By Distribution Channels 
     6.1. Introduction & Definition
     6.2. Key Findings / Developments
     6.3. Key Trends
     6.4. Market Value Forecast By Distribution Channels, 2014–2024
             6.4.1. Hospital Pharmacies
             6.4.2. Online Pharmacies
             6.4.3. Independent Pharmacies & Drug Stores
     6.5. Market Attractiveness By Distribution Channels 

7. Global Non-opioid Pain Patch Market Analysis and Forecasts, By Region
     7.1. Key Findings
     7.2. Policies and Regulations
     7.3. Market Value Forecast By Region
             7.3.1. North America 
             7.3.2. Europe 
             7.3.3. Asia Pacific 
             7.3.4. Latin America 
             7.3.5. Middle East and Africa 
     7.4. Market Attractiveness By Country/Region

8. North America Non-opioid Pain Patch Market Analysis and Forecast
     8.1. Introduction
             8.1.1. Key Findings
             8.1.2. Policies and Regulations
             8.1.3. Key Trends
     8.2. Market Value Forecast By Non-opioid Pain Patch Type, 2014–2024
             8.2.1. Lidocaine Patches
             8.2.2. Diclofenac Patches
             8.2.3. Methyl Salicylate Patches
             8.2.4. Capsaicin Patches
             8.2.5. Ketoprofen Patches
             8.2.6. Others
     8.3. Market Value Forecast By Distribution Channels, 2014–2024
             8.3.1. Hospital Pharmacies
             8.3.2. Online Pharmacies
             8.3.3. Independent Pharmacies & Drug Stores
     8.4. Market Value Forecast By Country, 2014–2024
             8.4.1. U.S.
             8.4.2. Canada
     8.5. Market Attractiveness Analysis 
             8.5.1. By Non-opioid Pain Patch Type 
             8.5.2. By Distribution Channels 
             8.5.3. By Country

9. Europe Non-opioid Pain Patch Market Analysis and Forecast
     9.1. Introduction
             9.1.1. Key Findings
             9.1.2. Policies and Regulations
             9.1.3. Key Trends
     9.2. Market Value Forecast By Non-opioid Pain Patch Type, 2014–2024
             9.2.1. Lidocaine Patches
             9.2.2. Diclofenac Patches
             9.2.3. Methyl Salicylate Patches
             9.2.4. Capsaicin Patches
             9.2.5. Ketoprofen Patches
             9.2.6. Others
     9.3. Market Value Forecast By Distribution Channels, 2014–2024
             9.3.1. Hospital Pharmacies
             9.3.2. Online Pharmacies
             9.3.3. Independent Pharmacies & Drug Stores
     9.4. Market Value Forecast By Country, 2014–2024
             9.4.1. U.K.
             9.4.2. Germany
             9.4.3. France
             9.4.4. Italy
             9.4.5. Spain
             9.4.6. Russia
             9.4.7. Rest of Europe
     9.5. Market Attractiveness Analysis 
             9.5.1. By Non-opioid Pain Patch Type 
             9.5.2. By Distribution Channels 
             9.5.3. By Country

10. Asia Pacific Non-opioid Pain Patch Market Analysis and Forecast
     10.1. Introduction
             10.1.1. Key Findings
             10.1.2. Policies and Regulations
             10.1.3. Key Trends
     10.2. Market Value Forecast By Non-opioid Pain Patch Type, 2014–2024
             10.2.1. Lidocaine Patches
             10.2.2. Diclofenac Patches
             10.2.3. Methyl Salicylate Patches
             10.2.4. Capsaicin Patches
             10.2.5. Ketoprofen Patches
             10.2.6. Others
     10.3. Market Value Forecast By Distribution Channels, 2014–2024
             10.3.1. Hospital Pharmacies
             10.3.2. Online Pharmacies
             10.3.3. Independent Pharmacies & Drug Stores
     10.4. Market Value Forecast By Country, 2014–2024
             10.4.1. India
             10.4.2. China
             10.4.3. Japan
             10.4.4. Australia & New Zealand
             10.4.5. Rest of Asia Pacific
     10.5. Market Attractiveness Analysis 
             10.5.1. By Non-opioid Pain Patch Type 
             10.5.2. By Distribution Channels 
             10.5.3. By Country

11. Latin America Non-opioid Pain Patch Market Analysis and Forecast
     11.1. Introduction
             11.1.1. Key Findings
             11.1.2. Policies and Regulations
             11.1.3.. Key Trends
     11.2. Market Value Forecast By Non-opioid Pain Patch Type, 2014–2024
             11.2.1. Lidocaine Patches
             11.2.2. Diclofenac Patches
             11.2.3. Methyl Salicylate Patches
             11.2.4. Capsaicin Patches
             11.2.5. Ketoprofen Patches
             11.2.6. Others
     11.3. Market Value Forecast By Distribution Channels, 2014–2024
             11.3.1. Hospital Pharmacies
             11.3.2. Online Pharmacies
             11.3.3. Independent Pharmacies & Drug Stores
     11.4. Market Value Forecast By Country, 2014–2024
             11.4.1. Brazil
             11.4.2. Mexico
             11.4.3. Rest of Latin America
     11.5. Market Attractiveness Analysis 
             11.5.1. By Non-opioid Pain Patch Type 
             11.5.2. By Distribution Channels 
             11.5.3. By Country

12. Middle East and Africa Non-opioid Pain Patch Market Analysis and Forecast
     12.1. Introduction
             12.1.1. Key Findings
             12.1.2. Policies and Regulations
             12.1.3. Key Trends
     12.2. Market Value Forecast By Non-opioid Pain Patch Type, 2014–2024
             12.2.1. Lidocaine Patches
             12.2.2. Diclofenac Patches
             12.2.3. Methyl Salicylate Patches
             12.2.4. Capsaicin Patches
             12.2.5. Ketoprofen Patches
             12.2.6. Others
     12.3. Market Value Forecast By Distribution Channels, 2014–2024
             12.3.1. Hospital Pharmacies
             12.3.2. Online Pharmacies
             12.3.3. Independent Pharmacies & Drug Stores
     12.4. Market Value Forecast By Country, 2014–2024
             12.4.1. South Africa
             12.4.2. GCC Countries
             12.4.3. Rest of Middle East and Africa
     12.5. Market Attractiveness Analysis 
             12.5.1. By Non-opioid Pain Patch Type 
             12.5.2. By Distribution Channels 
             12.5.3. By Country

13. Competition Landscape
     13.1. Market Player – Competition Matrix (By Tier and Size of companies)
     13.2. Market Share Analysis By Company - 2016 (Expected)
     13.3. Company Profiles (Details – Overview, Financials, Recent Developments, Strategy)
             13.3.1. Acorda Therapeutics, Inc.
                        13.3.1.1 Company Overview (HQ, Business Segments, Employee Strengths)
                        13.3.1.2 Financial Overview
                        13.3.1.3 Product Portfolio
                        13.3.1.4 SWOT Analysis
                        13.3.1.5 Strategic Overview
             13.3.2. ALLERGAN
                        13.3.1.1 Company Overview (HQ, Business Segments, Employee Strengths)
                        13.3.1.2 Financial Overview
                        13.3.1.3 Product Portfolio
                        13.3.1.4 SWOT Analysis
                        13.3.1.5 Strategic Overview
             13.3.3. Endo International plc 
                        13.3.1.1 Company Overview (HQ, Business Segments, Employee Strengths)
                        13.3.1.2 Financial Overview
                        13.3.1.3 Product Portfolio
                        13.3.1.4 SWOT Analysis
                        13.3.1.5 Strategic Overview
             13.3.4. GlaxoSmithKline plc
                        13.3.1.1 Company Overview (HQ, Business Segments, Employee Strengths)
                        13.3.1.2 Financial Overview
                        13.3.1.3 Product Portfolio
                        13.3.1.4 SWOT Analysis
                        13.3.1.5 Strategic Overview
             13.3.5. Hisamitsu Pharmaceutical Co.,Inc.
                        13.3.1.1 Company Overview (HQ, Business Segments, Employee Strengths)
                        13.3.1.2 Financial Overview
                        13.3.1.3 Product Portfolio
                        13.3.1.4 SWOT Analysis
                        13.3.1.5 Strategic Overview
             13.3.6. IBSA Institut Biochimque SA
                        13.3.1.1 Company Overview (HQ, Business Segments, Employee Strengths)
                        13.3.1.2 Financial Overview
                        13.3.1.3 Product Portfolio
                        13.3.1.4 SWOT Analysis
                        13.3.1.5 Strategic Overview
             13.3.7. Mylan N.V. 
                        13.3.1.1 Company Overview (HQ, Business Segments, Employee Strengths)
                        13.3.1.2 Financial Overview
                        13.3.1.3 Product Portfolio
                        13.3.1.4 SWOT Analysis
                        13.3.1.5 Strategic Overview
             13.3.8. Pfizer, Inc.
                        13.3.1.1 Company Overview (HQ, Business Segments, Employee Strengths)
                        13.3.1.2 Financial Overview
                        13.3.1.3 Product Portfolio
                        13.3.1.4 SWOT Analysis
                        13.3.1.5 Strategic Overview
             13.3.9. TEH SENG Pharmaceutical Mfg. Co., Ltd.
                        13.3.1.1 Company Overview (HQ, Business Segments, Employee Strengths)
                        13.3.1.2 Financial Overview
                        13.3.1.3 Product Portfolio
                        13.3.1.4 SWOT Analysis
                        13.3.1.5 Strategic Overview
             13.3.10. Teikoku Seiyaku Co., Ltd.
                        13.3.1.1 Company Overview (HQ, Business Segments, Employee Strengths)
                        13.3.1.2 Financial Overview
                        13.3.1.3 Product Portfolio
                        13.3.1.4 SWOT Analysis
                        13.3.1.5 Strategic Overview
             13.3.11. Others

List of Figures

Figure 01: Global Non-opioid Pain Patch Market Size (US$ Mn) Forecast, 2014–2024
Figure 02: Global Non-opioid Pain Patch Market Value Share, by Non-opioid Pain Patch Type, 2016 and 2024
Figure 03: Global Lidocaine Patches Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, 2014–2024
Figure 04: Global Diclofenac Patches Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, 2014–2024
Figure 05: Global Methyl Salicylate Patches Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, 2014–2024
Figure 06: Global Capsaicin Patches Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, 2014–2024
Figure 07: Global Ketoprofen Patches Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, 2014–2024
Figure 08: Global Others Market Revenue (US$ Mn) and
Figure 09: Global Non-opioid Pain Patch Market Attractiveness, by Non-opioid Pain Patch Type, 2016-2024
Figure 10: Global Non-opioid Pain Patch Market Value Share, by Distribution Channel, 2016 and 2024
Figure 11: Global Non-opioid Pain Patch Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Hospital Pharmacies, 2014–2024
Figure 12: Global Non-opioid Pain Patch Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Online Pharmacies, 2014–2024
Figure 13: Global Non-opioid Pain Patch Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Independent Pharmacies & Drug Stores, 2014–2024
Figure 14: Global Non-opioid Pain Patch Market Attractiveness, by Distribution Channel, 2016–2024
Figure 15: Global Non-opioid Pain Patch Market Value Share, by Region, 2016 and 2024
Figure 16: Global Non-opioid Pain Patch Market Attractiveness, by Region, 2016–2024
Figure 17: North America Non-opioid Pain Patch Market Size (US$ Mn) Forecast, 2014–2024
Figure 18: North America Non-opioid Pain Patch Market Attractiveness, by Country, 2016–2024
Figure 19: North America Non-opioid Pain Patch Market Value Share, by Country, 2016 and 2024
Figure 20: North America Non-opioid Pain Patch Market Value Share, by Non-opioid Pain Patch Type, 2016 and 2024
Figure 21: North America Non-opioid Pain Patch Market Value Share, by Distribution Channel, 2016 and 2024
Figure 22: North America Non-opioid Pain Patch Market Attractiveness, by Non-opioid Pain Patch Type, 2016–2024
Figure 23: North America Non-opioid Pain Patch Market Attractiveness, by Distribution Channel, 2016–2024
Figure 24: Europe Non-opioid Pain Patch Market Size (US$ Mn) Forecast, 2014–2024
Figure 25: Europe Non-opioid Pain Patch Market Attractiveness, by Country, 2016–2024
Figure 26: Europe Non-opioid Pain Patch Market Value Share, by Country/Sub-region, 2016 and 2024
Figure 27: Europe Non-opioid Pain Patch Market Value Share, by Non-opioid Pain Patch Type, 2016 and 2024
Figure 28: Europe Non-opioid Pain Patch Market Value Share, by Distribution Channel, 2016 and 2024
Figure 29: Europe Non-opioid Pain Patch Market Attractiveness, by Non-opioid Pain Patch Type, 2016-2024
Figure 30: Europe Non-opioid Pain Patch Market Attractiveness, by Distribution Channel, 2016-2024
Figure 31: Asia Pacific Non-opioid Pain Patch Market Size (US$ Mn) Forecast, 2014–2024
Figure 32: Asia Pacific Non-opioid Pain Patch Market Attractiveness, by Country, 2016–2024
Figure 33: Asia Pacific Non-opioid Pain Patch Market Value Share, by Country/Sub-Region, 2016 and 2024
Figure 34: Asia Pacific Non-opioid Pain Patch Market Value Share, by Non-opioid Pain Patch Type, 2016 and 2024
Figure 35: Asia Pacific Non-opioid Pain Patch Market Value Share, by Distribution Channel, 2016 and 2024
Figure 36: Asia Pacific Non-opioid Pain Patch Market Attractiveness, by Non-opioid Pain Patch Type, 2016–2024
Figure 37: Asia Pacific Non-opioid Pain Patch Market Attractiveness, by Distribution Channel, 2016–2024
Figure 38: Latin America Non-opioid Pain Patch Market Size (US$ Mn) Forecast, 2014–2024
Figure 39: Latin America Non-opioid Pain Patch Market Attractiveness, by Country, 2016–2024
Figure 40: Latin America Non-opioid Pain Patch Market Value Share, by Country/Sub-Region, 2016 and 2024
Figure 41: Latin America Non-opioid Pain Patch Market Value Share, by Non-opioid Pain Patch Type, 2016 and 2024
Figure 42: Latin America Non-opioid Pain Patch Market Value Share, by Distribution Channel, 2016 and 2024
Figure 43: Latin America Non-opioid Pain Patch Market Attractiveness, by Non-opioid Pain Patch Type, 2016-2024
Figure 44: Latin America Non-opioid Pain Patch Market Attractiveness, by Distribution Channel, 2016-2024
Figure 45: Middle East & Africa Non-opioid Pain Patch Market Size (US$ Mn) Forecast, 2014–2024
Figure 46: Middle East & Africa Non-opioid Pain Patch Market Attractiveness, by Country, 2016–2024
Figure 47: Middle East & Africa Non-opioid Pain Patch Market Value Share, by Country/Sub-Region, 2016 and 2024
Figure 48: Middle East & Africa Non-opioid Pain Patch Market Value Share, by Non-opioid Pain Patch Type, 2016 and 2024
Figure 49: Middle East & Africa Non-opioid Pain Patch Market Value Share, by Distribution Channel, 2016 and 2024
Figure 50: Middle East & Africa Non-opioid Pain Patch Market Attractiveness, by Non-opioid Pain Patch Type, 2016-2024
Figure 51: Middle East & Africa Non-opioid Pain Patch Market Attractiveness, by Distribution Channel, 2016-2024
Figure 52: Global Non-opioid Pain Patch Market Share, by Company, 2016 (Expected)

List of Tables

Table 01: Global Non-opioid Pain Patch Market Size (US$ Mn) Forecast, by Non-opioid Pain Patch Type, 2014–2024
Table 02: Global Non-opioid Pain Patch Market Size (US$ Mn) Forecast, by Distribution Channel, 2014–2024
Table 03: Global Non-opioid Pain Patch Market Size (US$ Mn) Forecast, by Region, 2014–2024
Table 04: North America Non-opioid Pain Patch Market Size (US$ Mn) Forecast, by Country, 2014–2024
Table 05: North America Non-opioid Pain Patch Market Size (US$ Mn) Forecast, by Non-opioid Pain Patch Type, 2014–2024
Table 06: North America Non-opioid Pain Patch Market Size (US$ Mn) Forecast, by Distribution Channel, 2014–2024
Table 07: Europe Non-opioid Pain Patch Market Size (US$ Mn) Forecast, by Country/Sub-region, 2014–2024
Table 08: Europe Non-opioid Pain Patch Market Size (US$ Mn) Forecast, by Non-opioid Pain Patch Type, 2014–2024
Table 09: Europe Non-opioid Pain Patch Market Size (US$ Mn) Forecast, by Distribution Channel, 2014–2024
Table 10: Asia Pacific Non-opioid Pain Patch Market Size (US$ Mn) Forecast, by Country/Sub-Region, 2014–2024
Table 11: Asia Pacific Non-opioid Pain Patch Market Size (US$ Mn) Forecast, by Non-opioid Pain Patch Type, 2014–2024
Table 12: Asia Pacific Non-opioid Pain Patch Market Size (US$ Mn) Forecast, by Distribution Channel, 2014–2024
Table 13: Latin America Non-opioid Pain Patch Market Size (US$ Mn) Forecast, by Country/Sub-Region, 2014–2024
Table 14: Latin America Non-opioid Pain Patch Market Size (US$ Mn) Forecast, by Non-opioid Pain Patch Type, 2014–2024
Table 15: Latin America Non-opioid Pain Patch Market Size (US$ Mn) Forecast, by Distribution Channel, 2014–2024
Table 16: Middle East & Africa Non-opioid Pain Patch Market Size (US$ Mn) Forecast, by Country/Sub-Region, 2014–2024
Table 17: Middle East & Africa Non-opioid Pain Patch Market Size (US$ Mn) Forecast, by Non-opioid Pain Patch Type, 2014–2024
Table 18: Middle East & Africa Non-opioid Pain Patch Market Size (US$ Mn) Forecast, by Distribution Channel, 2014–2024

Global Non-opioid Pain Patch Market: Overview

Transdermal drug delivery systems (TDDS) is a systemic drug therapy approach which eliminates the risk of gastro-intestinal adverse reactions. The low concentrations of drugs are delivered using these systems as first pass metabolism in the liver is bypassed by using them. The non-opioid pain patch market is witnessing a steady growth due to stable adoption rates. Currently there are three generations of the transdermal drug delivery systems in the market, out of which majority of the FDA approved patches belong to first-generation products. Non-opioid pain patches offer efficient transdermal drug delivery option for the treatment of various pain conditions for a prolonged period of time. The non-opioid pain patches have various functional features such as occlusive backing film prevents inadvertent drug loss, and also improves drug penetration, the protective drug release liner maintains the patch integrity, and prevents accidental exposure before its application.

The market overview section of the report comprises qualitative analysis of the overall non-opioid pain patch market considering the factors determining the market dynamics such as drivers, restraints and opportunities, along with Porter’s five force analysis and market attractiveness analysis. In addition, such as market opportunity analysis for the patch type, and distribution channels, and key industry developments has also been provided. Key industry developments include the major events occurred in past decade and are expected to occur during the forecast period which are likely to affect the market dynamics. The WHO pain ladder for pain management treatment has also been provided, along with the percentage prevalence rates of acute pain by region as well as by countries. The snapshot of patch design technologies has been given in the market overview section.

Global Non-opioid Pain Patch Market: Market Segmentation

The global non-opioid pain patch market has been segmented on the basis of patch type, and distribution channels. In terms of patch type, the global non-opioid pain patch market is divided into lidocaine patches, diclofenac patches, methyl salicylate patches, capsaicin patches, ketoprofen patches, and others. Furthermore, on the basis of distribution channels, the global non-opioid pain patch market has been classified as hospital pharmacies, online pharmacies, and independent pharmacies & drug stores. The market for these patch type, and distribution channels has been extensively analyzed on the basis of factors such as non-opioid patch usage pattern, sales revenue, geographic presence and technological developments. The market size and forecast in terms of revenue (US$ million) for each of these segments have been provided for the period 2014 to 2024, considering 2015 as the base year. The report also provides the compounded annual growth rate (CAGR) for each segment for the forecast period 2016 to 2024.

Geographically, the non-opioid pain patch market has been classified into five segments namely, North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. The market size and forecast for each region has been provided for the period 2014 to 2024, in terms of patch type, and distribution channels, along with the CAGR (%) for the forecast period 2016 to 2024.

Global Non-opioid Pain Patch Market: Competitive Landscape

The report also provides a section on the competitive landscape, wherein the market share analysis of leading players in the global non-opioid pain patch market, in terms of percentage share in 2016 (expected) has been discussed. A list of recommendations has also been included for new entrants as well as existing market players to help them establish a strong presence in the market and increase their market share. The report concludes with the profiles of major players in the global non-opioid pain patch market such as Acorda Therapeutics, Inc., ALLERGAN, Endo International plc, GlaxoSmithKline plc, Hisamitsu Pharmaceutical Co.,Inc., IBSA Institut Biochimque SA, Mylan N.V. , Pfizer, Inc., TEH SENG Pharmaceutical Mfg. Co., Ltd., and Teikoku Seiyaku Co., Ltd., among others. The major market players are evaluated on various parameters such as company overview, financial overview, product portfolio, business strategies and recent developments.

The global Non-opioid Pain Patch market has been segmented as follows:

  • Global Non-opioid Pain Patch Market, by Non-opioid Pain Patch Type
    • Lidocaine Patches
    • Diclofenac Patches
    • Methyl Salicylate Patches
    • Capsaicin Patches
    • Ketoprofen Patches
    • Others
       
  • Global Non-opioid Pain Patch Market, by Distribution Channel
    • Hospital Pharmacies
    • Online Pharmacies
    • Independent Pharmacies & Drug Stores
       
  • Global Non-opioid Pain Patch Market, by Geography
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East & Africa


 
 
Back To Top